Patents by Inventor Berna DOGAN

Berna DOGAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor
    Patent number: 12435074
    Abstract: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of BCL-2.
    Type: Grant
    Filed: February 10, 2021
    Date of Patent: October 7, 2025
    Assignee: BAHCESEHIR UNIVERSITESI
    Inventors: Muge Didem Orhan, Serdar Durdagi, Berna Dogan, Seyma Calis, Gurbet Cacan, Timucin Avsar
  • Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor
    Patent number: 12398128
    Abstract: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of BCL-2.
    Type: Grant
    Filed: February 10, 2021
    Date of Patent: August 26, 2025
    Assignee: BAHCESEHIR UNIVERSITESI
    Inventors: Serdar Durdagi, Timucin Avsar, Muge Didem Orhan, Gurbet Cacan, Berna Dogan, Seyma Calis
  • Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor
    Patent number: 12384746
    Abstract: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of BCL-2.
    Type: Grant
    Filed: February 10, 2021
    Date of Patent: August 12, 2025
    Assignee: BAHCESEHIR UNIVERSITESI
    Inventors: Muge Didem Orhan, Timucin Avsar, Berna Dogan, Gurbet Cacan, Seyma Calis, Serdar Durdagi
  • Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor
    Patent number: 12318368
    Abstract: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of BCL-2.
    Type: Grant
    Filed: February 10, 2021
    Date of Patent: June 3, 2025
    Assignee: BAHCESEHIR UNIVERSITESI
    Inventors: Berna Dogan, Serdar Durdagi, Gurbet Cacan, Seyma Calis, Timucin Avsar, Muge Didem Orhan
  • Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor
    Patent number: 12297175
    Abstract: The invention relates to compound shown with formula (I) for a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of BCL-2.
    Type: Grant
    Filed: February 10, 2021
    Date of Patent: May 13, 2025
    Assignee: BAHCESEHIR UNIVERSITESI
    Inventors: Muge Didem Orhan, Berna Dogan, Seyma Calis, Gurbet Cacan, Timucin Avsar, Serdar Durdagi
  • PHYSICS-DRIVEN DISCOVERY OF NOVEL SMALL THERAPEUTIC COMPOUNDS FOR USE AS A BCL-2 INHIBITOR
    Publication number: 20230109522
    Abstract: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of BCL-2.
    Type: Application
    Filed: February 10, 2021
    Publication date: April 6, 2023
    Inventors: Serdar DURDAGI, Timucin AVSAR, Muge Didem ORHAN, Gurbet CACAN, Berna DOGAN, Seyma CALIS
  • PHYSICS-DRIVEN DISCOVERY OF NOVEL SMALL THERAPEUTIC COMPOUNDS FOR USE AS A BCL-2 INHIBITOR
    Publication number: 20230099876
    Abstract: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of BCL-2.
    Type: Application
    Filed: February 10, 2021
    Publication date: March 30, 2023
    Inventors: Muge Didem ORHAN, Serdar DURDAGI, Berna DOGAN, Seyma CALIS, Gurbet CACAN, Timucin AVSAR
  • PHYSICS-DRIVEN DISCOVERY OF NOVEL SMALL THERAPEUTIC COMPOUNDS FOR USE AS A BCL-2 INHIBITOR
    Publication number: 20230088086
    Abstract: The invention relates to compound shown with formula (I) for a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of BCL-2.
    Type: Application
    Filed: February 10, 2021
    Publication date: March 23, 2023
    Inventors: Muge Didem ORHAN, Berna DOGAN, Seyma CALIS, Gurbet CACAN, Timucin AVSAR, Serdar DURDAGI
  • PHYSICS-DRIVEN DISCOVERY OF NOVEL SMALL THERAPEUTIC COMPOUNDS FOR USE AS A BCL-2 INHIBITOR
    Publication number: 20230090414
    Abstract: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of BCL-2.
    Type: Application
    Filed: February 10, 2021
    Publication date: March 23, 2023
    Inventors: Berna DOGAN, Serdar DURDAGI, Gurbet CACAN, Seyma CALIS, Timucin AVSAR, Muge Didem ORHAN
  • PHYSICS-DRIVEN DISCOVERY OF NOVEL SMALL THERAPEUTIC COMPOUNDS FOR USE AS A BCL-2 INHIBITOR
    Publication number: 20230074698
    Abstract: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of BCL-2.
    Type: Application
    Filed: February 10, 2021
    Publication date: March 9, 2023
    Inventors: Muge Didem ORHAN, Timucin AVSAR, Berna DOGAN, Gurbet CACAN, Seyma CALIS, Serdar DURDAGI